Skip to main content
. 2019 Jan 29;73(3):291–301. doi: 10.1016/j.jacc.2018.10.066

Table 1.

Characteristics of Study Participants

All Participants (N = 1,769) Participants Without Adverse Plaque (n = 1,161) Participants With Adverse Plaque (n = 608) p Value
Male 997 (56) 545 (47) 452 (74) <0.001
Age, yrs 57.6 ± 9.5 55.9 ± 9.8 60.8 ± 7.8 <0.001
Body mass index, kg/m2 29.6 ± 5.5 30.0 ± 5.8 28.8 ± 4.8 <0.001
Atrial fibrillation 34 (1.9) 20 (1.7) 14 (2.3) 0.399
Smoking status <0.001
 Current smoker 330 (19) 208 (18) 122 (20)
 Ex-smoker 593 (34) 357 (31) 236 (39)
 Nonsmoker 845 (48) 595 (51) 250 (41)
Hypertension 608 (35) 373 (32) 235 (39) 0.005
Diabetes 196 (11) 128 (11) 68 (11) 0.919
Family history of CHD 765 (43) 507 (44) 258 (42) 0.552
Previous CHD 178 (10) 75 (6.5) 103 (17) <0.001
Previous PAD 31 (1.8) 19 (1.6) 12 (2) 0.608
Anginal symptoms <0.001
 Typical angina 654 (37) 347 (30) 307 (51)
 Atypical angina 432 (24) 293 (25) 139 (23)
 Nonanginal 683 (39) 521 (45) 162 (27)
ASSIGN 17.9 ± 11.0 16.1 ± 10.9 21.4 ± 10.6 <0.001
Coronary artery calcium score (Agatston units) 21 [0–230] 0 [0–34] 281 [89–775] <0.001

Values are n (%), mean ± SD, or median [interquartile range]. Values in bold indicate statistical significance.

ASSIGN = ASsessing cardiovascular risk using Scottish Intercollegiate Guidelines Network guidelines; CHD = coronary heart disease; PAD = peripheral arterial disease.